Most start-ups wouldn’t employ the strategy that PostEra has. In fact, many of its business decisions seem counterintuitive. PostEra owns little to no intellectual property (IP) on its early work, ...
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. In this episode, Thomas Betts chats with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback